Pimozide Inhibits CatSper Activity, Impairs Hyperactivation and the Acrosome Reaction in Human Spermatozoa
International Journal of Molecular Sciences · 13.06.2026 · 27 (12) · 5357
DOI: 10.3390/ijms27125357 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.06.2026. Verfasst von Jorge Arturo Torres Juárez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Biomédica Avanzada, Facultad de Medicina, Universidad Autónoma de Querétaro (UAQ), Santiago de Querétaro 76010, Mexico. Hauptthemen laut MEDLINE: Pimozide, Acrosome Reaction, Spermatozoa, Calcium Channels. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación, CONAHCYT.
Abstract (Originalsprache)
Health, social, and ethical considerations highlight the need for new male contraceptives. Pimozide is an FDA approved drug known to block T-type calcium channels and which shares structural similarities with mibefradil, a proven antagonist of the CatSper channel. In this study, we examined the effect of pimozide on CatSper, a key target for non-hormonal male contraception. Molecular docking and molecular dynamics simulations were carried out to assess how pimozide binds within the channel pore, and binding energies were estimated using MM-GBSA. To determine its impact on sperm function, we evaluated hyperactivation, the acrosome reaction, and CatSper activity. Our computational analyses indicate that pimozide functions as a pore blocker of the CatSper channel. Experimental findings further support this, showing that pimozide inhibits CatSper activity, and impairs hyperactivation and the acrosome reaction in human spermatozoa. Overall, these results identify pimozide as a novel CatSper antagonist and propose a binding mode, offering a basis for the rational design of reversible, non-hormonal male contraceptives that target the CatSper channel.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigación Biomédica Avanzada, Facultad de Medicina, Universidad Autónoma de Querétaro (UAQ), Santiago de Querétaro 76010, Mexico.
- Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), Ciudad de México 04510, Mexico.
- Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología (IBT), Universidad Nacional Autónoma de México (UNAM), Cuernavaca 62210, Mexico.
ORCID-Profile: Jorge Arturo Torres Juárez, Ana Gabriela Hernández Puga, Esperanza Mata Martínez, Ana Alicia Sánchez Tusie
Förderung
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
- CONAHCYT
Zitieren
APA
Torres Juárez, J. A., Hernández Puga, A. G., Mata Martínez, E., Treviño Santa Cruz, C. L., & Sánchez Tusie, A. A. (2026). Pimozide Inhibits CatSper Activity, Impairs Hyperactivation and the Acrosome Reaction in Human Spermatozoa. International Journal of Molecular Sciences, 27(12), 5357. https://doi.org/10.3390/ijms27125357
Vancouver
Torres Juárez JA, Hernández Puga AG, Mata Martínez E, Treviño Santa Cruz CL, Sánchez Tusie AA. Pimozide Inhibits CatSper Activity, Impairs Hyperactivation and the Acrosome Reaction in Human Spermatozoa. International Journal of Molecular Sciences. 2026;27(12):5357. doi:10.3390/ijms27125357
BibTeX
@article{TorresJurez2026,
author = {Torres Juárez, Jorge Arturo and Hernández Puga, Ana Gabriela and Mata Martínez, Esperanza and Treviño Santa Cruz, Claudia Lydia and Sánchez Tusie, Ana Alicia},
title = {Pimozide Inhibits CatSper Activity, Impairs Hyperactivation and the Acrosome Reaction in Human Spermatozoa},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5357},
doi = {10.3390/ijms27125357}
}
EUVIMED